Investor Relations Captor Therapeutics ®
Candidate for member of the Supervisory Board of the Company
Publication date:
Publication time:
Current report no. 26/2025
Date of drafting: 13.06.2025
Subject: Candidate for member of the Supervisory Board of the Company
Legal basis: Article 56(1)(2) of the Act on Offering - current information.
The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the "Company"), hereby announces that in connection with the Ordinary General Meeting of the Company scheduled for June 26, 2025, it has received a draft resolution from the Company's shareholder - Otwarty Fundusz Emerytalny PZU “Złota Jesień”, represented by Powszechne Towarzystwo Emerytalne PZU S.A., regarding the appointment of Mr. Andrew Galazek to the Company's Supervisory Board.
The Company, in the attachment to this report, discloses the CV of the above-mentioned candidate.
Detailed legal basis: § 19(1)(4) of the Regulation of the Minister of Finance of 29 March 2018 on current and periodic information provided by issuers of securities and conditions for recognising as equivalent information required by the laws of a non-member state.